More from McGill in the Headlines
- In the Headlines
- in_the_headlines https://secureweb.mcgill.ca/newsroom
The brains of highly intelligent children appear to develop in a distinctive and surprising way that distinguishes them from less intelligent children, according to a study from the National Institute of Mental Health. Drs. Jason Lerch and Alan Evans of McGill's MNI provided analysis of data with the help of a unique database.
In a study published in the April issue of the journal Lancet Oncology, Drs. Jean-Paul Collet and Stan Shapiro suggest that antidepressants can retard the development of colorectal tumours.
While testing a robotic drill on Ellesmere Island at the Eureka weather station, McGill polar biologist Lyle Whyte discovered samples of about 60 different types of microbes that had lain dormant for 20,000 years, some at -16ºC.
Terry Mosher (a.k.a. the Gazette cartoonist Aislin) poignantly describes a visit to Tanzania with a team of medical experts from McGill. The group went to build links with hospitals and clinics.
The pressure to keep the teaching of evolution out of schools is enormous and omission is the method of dealing with it in science education in the deep south of the US. PhD student Jason Wiles tells his story.
Discrimination plagues the health services and care of elderly homosexuals, according to a recent McGill study by Shari Brotman.
Dr. Jody Heymann has produced the most comprehensive and groundbreaking study on how globalization is affecting working families around the world. The study is a wake-up call for policy makers and employers.
A compound isolated from coral has shown the ability to slow down and possibly prevent virus replication and may hold promise as a cancer treatment, according to a study by McGill biochemist Jerry Pelletier and his colleagues.
Tom Hudson, Director of the McGill University and Génome Québec Innovation Centre, leading Canadian investigator in the International HapMap Project and a "refreshingly modest star," is profiled in the Gazette.
Genes predisposing us to certain diseases may rely on some other switching mechanism to activate the DNA. Dr Moshe Szyf's pioneering work in epigenetics is highlighted.